Live healthier, stronger and sharper for longer
Daily longevity reporting — trending research, working protocols, and the supplements and peptides moving the needle on healthspan.
Rapamycin in 2026: What the Latest Longevity Trials Actually Show
Intermittent low-dose rapamycin keeps producing the most consistent lifespan signal of any drug tested in mammals. Here is what the 2026 data adds, and how serious longevity protocols are evolving.
GLP-1 Drugs Beyond Weight Loss: The Longevity Signal Nobody Expected
New cardiovascular, kidney and cognitive outcome data is reframing GLP-1 receptor agonists as potential healthspan drugs, not just appetite suppressants.
NMN vs NR in 2026: Which NAD+ Precursor Actually Moves the Needle?
Both NMN and NR reliably raise NAD+, but the functional outcomes — energy, muscle, vascular health — depend heavily on dose, form and what you stack them with.
BPC-157 in 2026: The Healing Peptide Every Athlete Is Talking About
BPC-157 is one of the most-used recovery peptides on the planet. The human data is thin but mechanistically rich — here is what serious users need to know.
Zone 2 Cardio: The Single Most Underrated Longevity Tool
If you could only do one thing for the next 30 years of healthspan, zone 2 cardio would be it. Here is the why, the how, and how to combine it with the rest of your stack.
Creatine for the Brain: The Longevity Case Beyond Muscle
Creatine is no longer just for the gym. The cognitive, mood and neuroprotection data now makes it one of the strongest evidence-backed longevity supplements available.
Sleep Architecture: The Longevity Lever Nobody Optimises Hard Enough
Deep sleep and REM are where the body and brain actually repair. Most longevity protocols underweight sleep optimisation — here is how to fix that.
Berberine in 2026: A Plant Alkaloid With Surprising Longevity Credentials
Berberine has been called nature's metformin. The reality is more nuanced — but for the right person, it is one of the strongest metabolic supplements available.
VO2 Max and Longevity: Why It May Be the Single Strongest Predictor of How Long You Live
A landmark JAMA cohort showed that going from low to elite VO2 max was associated with a larger mortality reduction than quitting smoking. Here is how to use that finding without overhyping it.
ApoB vs LDL Cholesterol: The Better Heart Disease Marker in 2026
Mendelian randomisation and discordance analyses now make ApoB — not LDL-C — the most accurate single number for atherosclerotic risk. Most people, and most doctors, still are not measuring it.
Sauna for Longevity: What the Finnish Studies Actually Prove
Four-to-seven sauna sessions a week is associated with a roughly 40% lower all-cause mortality risk in Finnish men. Here is what the evidence actually says, the biological mechanisms, and how to use heat therapy safely.
Continuous Glucose Monitors for Non-Diabetics: Worth It or Wearable Hype?
CGMs are now cheap, accurate and over-the-counter. For non-diabetics, they are a powerful 2-week experiment — not a permanent wearable. Here is what the evidence says and how to actually use one.